205 related articles for article (PubMed ID: 26944191)
21. Molecular regulation of the PAI-1 gene by hypoxia: contributions of Egr-1, HIF-1alpha, and C/EBPalpha.
Liao H; Hyman MC; Lawrence DA; Pinsky DJ
FASEB J; 2007 Mar; 21(3):935-49. PubMed ID: 17197388
[TBL] [Abstract][Full Text] [Related]
22. Nemo-like kinase as a negative regulator of nuclear receptor Nurr1 gene transcription in prostate cancer.
Wang J; Yang ZH; Chen H; Li HH; Chen LY; Zhu Z; Zou Y; Ding CC; Yang J; He ZW
BMC Cancer; 2016 Mar; 16():257. PubMed ID: 27036119
[TBL] [Abstract][Full Text] [Related]
23. HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas.
Gray MJ; Zhang J; Ellis LM; Semenza GL; Evans DB; Watowich SS; Gallick GE
Oncogene; 2005 Apr; 24(19):3110-20. PubMed ID: 15735682
[TBL] [Abstract][Full Text] [Related]
24. CREB binding to the hypoxia-inducible factor-1 responsive elements in the plasminogen activator inhibitor-1 promoter mediates the glucagon effect.
Dimova EY; Jakubowska MM; Kietzmann T
Thromb Haemost; 2007 Aug; 98(2):296-303. PubMed ID: 17721610
[TBL] [Abstract][Full Text] [Related]
25. The upstream stimulatory factor-2a inhibits plasminogen activator inhibitor-1 gene expression by binding to a promoter element adjacent to the hypoxia-inducible factor-1 binding site.
Samoylenko A; Roth U; Jungermann K; Kietzmann T
Blood; 2001 May; 97(9):2657-66. PubMed ID: 11313255
[TBL] [Abstract][Full Text] [Related]
26. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
[TBL] [Abstract][Full Text] [Related]
27. Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells.
Xie Y; Nakanishi T; Natarajan K; Safren L; Hamburger AW; Hussain A; Ross DD
Biochim Biophys Acta; 2015 Mar; 1849(3):317-27. PubMed ID: 25615818
[TBL] [Abstract][Full Text] [Related]
28. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
[TBL] [Abstract][Full Text] [Related]
29. Visualization of hypoxia-inducible factor 1α-p300 interactions in live cells by fluorescence resonance energy transfer.
Kim SY; Lee MJ; Na YR; Kim SY; Yang EG
J Cell Biochem; 2014 Feb; 115(2):271-80. PubMed ID: 23966271
[TBL] [Abstract][Full Text] [Related]
30. MnTE-2-PyP Suppresses Prostate Cancer Cell Growth via H
Zhu Y; Kosmacek EA; Chatterjee A; Oberley-Deegan RE
Antioxidants (Basel); 2020 Jun; 9(6):. PubMed ID: 32512786
[TBL] [Abstract][Full Text] [Related]
31. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.
Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG
Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546
[TBL] [Abstract][Full Text] [Related]
32. NF-κB suppresses HIF-1α response by competing for P300 binding.
Mendonça DB; Mendonça G; Aragão FJ; Cooper LF
Biochem Biophys Res Commun; 2011 Jan; 404(4):997-1003. PubMed ID: 21187066
[TBL] [Abstract][Full Text] [Related]
33. Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myeloma.
Viziteu E; Grandmougin C; Goldschmidt H; Seckinger A; Hose D; Klein B; Moreaux J
Br J Cancer; 2016 Mar; 114(5):519-23. PubMed ID: 26867162
[TBL] [Abstract][Full Text] [Related]
34. CREB stimulates GPX4 transcription to inhibit ferroptosis in lung adenocarcinoma.
Wang Z; Zhang X; Tian X; Yang Y; Ma L; Wang J; Yu Y
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846793
[TBL] [Abstract][Full Text] [Related]
35. Antiangiogenic action of redox-modulating Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin, MnTE-2-PyP(5+), via suppression of oxidative stress in a mouse model of breast tumor.
Rabbani ZN; Spasojevic I; Zhang X; Moeller BJ; Haberle S; Vasquez-Vivar J; Dewhirst MW; Vujaskovic Z; Batinic-Haberle I
Free Radic Biol Med; 2009 Oct; 47(7):992-1004. PubMed ID: 19591920
[TBL] [Abstract][Full Text] [Related]
36. The hepatitis E virus ORF3 protein stabilizes HIF-1alpha and enhances HIF-1-mediated transcriptional activity through p300/CBP.
Moin SM; Chandra V; Arya R; Jameel S
Cell Microbiol; 2009 Sep; 11(9):1409-21. PubMed ID: 19489936
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-inducible factor-1 in human breast and prostate cancer.
Kimbro KS; Simons JW
Endocr Relat Cancer; 2006 Sep; 13(3):739-49. PubMed ID: 16954428
[TBL] [Abstract][Full Text] [Related]
38. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer.
Salnikow K; Costa M; Figg WD; Blagosklonny MV
Cancer Res; 2000 Oct; 60(20):5630-4. PubMed ID: 11059752
[TBL] [Abstract][Full Text] [Related]
39. Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells.
Horii K; Suzuki Y; Kondo Y; Akimoto M; Nishimura T; Yamabe Y; Sakaue M; Sano T; Kitagawa T; Himeno S; Imura N; Hara S
Mol Cancer Res; 2007 Apr; 5(4):383-91. PubMed ID: 17426252
[TBL] [Abstract][Full Text] [Related]
40. Nuclear FGFR2 negatively regulates hypoxia-induced cell invasion in prostate cancer by interacting with HIF-1 and HIF-2.
Lee JE; Shin SH; Shin HW; Chun YS; Park JW
Sci Rep; 2019 Mar; 9(1):3480. PubMed ID: 30837551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
